OsteoCure Therapeutics
PrivateLast Round
Accelerator
May 27, 2026
Total Funding Raised
$350,000
Momentum
Top 50%
of companies Caplight tracks
Company Overview
OsteoCure Therapeutics operates in Healthcare & Life Sciences and is based in Durham, North Carolina. Its latest recorded funding round was an Accelerator round in May 2026.
OsteoCure Therapeutics is a biotechnology company that develops adenosine-based therapeutics to restore skeletal health, reverse bone loss, and accelerate bone repair.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Medical Devices, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
OsteoCure Therapeutics Comparables
Compare OsteoCure Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Moroxite F | 77% | |
| Bone Solutions, Inc. | 77% | |
| Skeletalis Bio | 71% |
For institutional investors. Book with your work email.
OsteoCure Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Accelerator | May 27, 2026 | ||||
| Accelerator | Apr 16, 2026 | ||||
| Accelerator | Oct 20, 2025 | ||||
| Accelerator | May 13, 2025 | ||||
| Debt | Nov 1, 2024 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
OsteoCure Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Plug and Play Tech Center | Accelerator |
| MedTech Innovator | Accelerator |
| SCbioDrive | Accelerator |
| North Carolina Biotechnology Center | Debt |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 27, 2026
Received funding from MedTech Innovator.
- May 13, 2025
Received funding from SCbioDrive.
For institutional investors. Book with your work email.
OsteoCure Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about OsteoCure Therapeutics's valuation, stock price, and market status.
Is OsteoCure Therapeutics a public or private company?
OsteoCure Therapeutics is a private company.
What is the current stock price of OsteoCure Therapeutics?
OsteoCure Therapeutics is a private company, so its shares have no public market price. Caplight tracks OsteoCure Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is OsteoCure Therapeutics worth (valuation)?
Valuation information for OsteoCure Therapeutics is not publicly available.
Can I buy OsteoCure Therapeutics stock?
OsteoCure Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was OsteoCure Therapeutics's last funding round?
OsteoCure Therapeutics's most recent funding round was Accelerator on May 27, 2026.
Who are the main investors in OsteoCure Therapeutics?
Key investors in OsteoCure Therapeutics include Plug and Play Tech Center, MedTech Innovator, SCbioDrive, North Carolina Biotechnology Center.
Will OsteoCure Therapeutics IPO soon?
No public IPO plans have been announced for OsteoCure Therapeutics.
How can I track OsteoCure Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in OsteoCure Therapeutics's shares on secondary markets.